Literature DB >> 12783283

Two unusual cases of diffuse acrodermatitis chronica atrophicans seronegative for Lyme borreliosis.

T G Berger1, C Schoerner, H Schell, M Simon, G Schuler, M Röllinghoff, A Gessner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12783283     DOI： 10.1007/s10096-003-0943-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  17 in total

1.  Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity.

Authors:  J A Hardin; A C Steere; S E Malawista
Journal:  N Engl J Med       Date:  1979-12-20       Impact factor: 91.245

2.  Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi.

Authors:  M Brunner; L H Sigal
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Scored antibody reactivity determined by immunoblotting shows an association between clinical manifestations and presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. Valaisiana in humans.

Authors:  K Ryffel; O Péter; B Rutti; A Suard; E Dayer
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  Absence of Borrelia burgdorferi-specific immune complexes in chronic fatigue syndrome.

Authors:  S E Schutzer; B H Natelson
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

5.  Acrodermatitis chronica atrophicans: a light and electron microscopic study.

Authors:  J de Koning; D J Tazelaar; J A Hoogkamp-Korstanje; J D Elema
Journal:  J Cutan Pathol       Date:  1995-02       Impact factor: 1.587

6.  The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer.

Authors:  E Asbrink; A Hovmark; B Hederstedt
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

Review 7.  Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes.

Authors:  E Asbrink
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1985

8.  Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans.

Authors:  R Wienecke; N Zöchling; U Neubert; E M Schlüpen; M Meurer; M Volkenandt
Journal:  J Invest Dermatol       Date:  1994-07       Impact factor: 8.551

9.  Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status.

Authors:  A Plörer; N Sepp; E Schmutzhard; S Krabichler; S Trobos; G Schauer; C Pahl; G Stöffler; P Fritsch
Journal:  J Invest Dermatol       Date:  1993-02       Impact factor: 8.551

10.  Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients.

Authors:  E Asbrink; A Hovmark; I Olsson
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12
View more
  2 in total

Review 1.  Immunoserological Diagnosis of Human Borrelioses: Current Knowledge and Perspectives.

Authors:  Emilie Talagrand-Reboul; Alice Raffetin; Pierre Zachary; Benoît Jaulhac; Carole Eldin
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

2.  Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group.

Authors:  Samuel Shor; Christine Green; Beatrice Szantyr; Steven Phillips; Kenneth Liegner; Joseph Jr Burrascano; Robert Bransfield; Elizabeth L Maloney
Journal:  Antibiotics (Basel)       Date:  2019-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.